Home

ASE Technology Holding Co., Ltd. American Depositary Shares (each representing (ASX)

12.34
-0.34 (-2.67%)
NYSE · Last Trade: Oct 22nd, 2:06 PM EDT
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors

Detailed Quote

Previous Close12.68
Open12.65
Bid12.34
Ask12.35
Day's Range12.34 - 12.66
52 Week Range6.940 - 13.10
Volume4,254,339
Market Cap54.40B
PE Ratio (TTM)-
EPS (TTM)-
Dividend & Yield0.3560 (2.88%)
1 Month Average Volume7,146,016

Chart

About ASE Technology Holding Co., Ltd. American Depositary Shares (each representing (ASX)

Ase Industrial Holding Ltd is a multifaceted company engaged in the design, manufacture, and distribution of various industrial products and solutions. Specializing in advanced materials and innovative manufacturing processes, the company serves a wide range of sectors, including construction, automotive, and electronics. By focusing on sustainability and technological advancements, Ase Industrial Holding aims to provide high-quality, efficient, and environmentally friendly products that meet the evolving needs of its customers. The company is committed to driving growth through strategic partnerships and investments in research and development. Read More

News & Press Releases

Life360 Debuts New Pet Tracker And Pet Recovery Features, Connecting The Whole Family In One App
Real-Time Tracking, Escape Alerts, and a Community-Powered Pet Finding Network Work Together to Unleash Unmatched Peace of Mind
By Life360, Inc. · Via GlobeNewswire · October 22, 2025
Vanguard Deepens Semiconductor Bet: Increased Stakes in Amkor Technology and Silicon Laboratories Signal Strategic Confidence
In a significant move signaling strategic confidence in the burgeoning semiconductor sector, Vanguard Personalized Indexing Management LLC has substantially increased its stock holdings in two key players: Amkor Technology (NASDAQ: AMKR) and Silicon Laboratories (NASDAQ: SLAB). The investment giant's deepened commitment, particularly evident during the second quarter of 2025, underscores a calculated bullish outlook on [...]
Via TokenRing AI · October 21, 2025
ASE and Analog Devices Announce Strategic Collaboration
ASE Technology Holding Co., Ltd. (NYSE: ASX, TAIEX: 3711), and Analog Devices, Inc. (NASDAQ: ADI), today announced strategic joint efforts in Penang, Malaysia with the signing of a binding Memorandum of Understanding.
By ASE Technology Holding Co., Ltd. · Via Business Wire · October 21, 2025
P/E Ratio Insights for ASE Technology Holding Cobenzinga.com
Via Benzinga · September 5, 2025
Metals & Mining Virtual Investor Conference: Presentations Now Available for Online Viewing
Company Executives Share Vision and Answer Questions Live at VirtualInvestorConferences.com
By Virtual Investor Conferences · Via GlobeNewswire · October 10, 2025
Earnings Scheduled For July 31, 2025benzinga.com
Via Benzinga · July 31, 2025
A Peek at ASE Tech Holding Co's Future Earningsbenzinga.com
Via Benzinga · July 30, 2025
Alterity Therapeutics Presents Positive Data from ATH434 Phase 2 Trial at the 2025 International Congress of Parkinson’s Disease and Movement Disorders
– Data demonstrate ATH434 slows disease progression and stabilizes orthostatic hypotension –
By ALTERITY THERAPEUTICS LIMITED · Via GlobeNewswire · October 9, 2025
US-Taiwan Alliance Forges a New Era in Secure AI, 5G/6G, and Quantum Computing
The United States and Taiwan are solidifying a strategic technological alliance, marking a pivotal moment in global innovation and geopolitical strategy. This partnership, focusing intently on secure 5G/6G networks, advanced Artificial Intelligence (AI), and groundbreaking Quantum Computing, is designed to enhance supply chain resilience, foster next-generation technological leadership, and counter the influence of authoritarian regimes. [...]
Via TokenRing AI · October 2, 2025
Metals & Mining Virtual Investor Conference Agenda Announced for October 7-9th
Company Executives Share Vision and Answer Questions Live at VirtualInvestorConferences.com
By Virtual Investor Conferences · Via GlobeNewswire · October 6, 2025
Alterity Therapeutics to Deliver Multiple Presentations at the 2025 International Congress of Parkinson’s Disease and Movement Disorders
– Data from ATH434-201 double-blind Phase 2 trial to be featured in oral session and multiple poster presentations –
By ALTERITY THERAPEUTICS LIMITED · Via GlobeNewswire · October 2, 2025
Life360 Launches Weekly Giveaway so Families Don’t Have to Dip Into Their ‘Fun Fund’
Whether it’s Rent, Gas, or Family Data Plans, the “Life360 Pays For…” Campaign Aims to Break the Budgetary Barriers to Family Connection
By Life360, Inc. · Via GlobeNewswire · September 23, 2025
Alterity Therapeutics Presents ATH434-201 Phase 2 Data at the American Neurological Association Annual Meeting
ATH434 demonstrated clinically meaningful efficacy in modifying disease progression and was well tolerated at both 50 and 75 mg doses
By ALTERITY THERAPEUTICS LIMITED · Via GlobeNewswire · September 15, 2025
Life360 Partners with AccuWeather to Deliver Real-Time Severe Weather Alerts to Families
New integration leverages Life360’s ad platform to deliver even more value to members, keeping loved ones informed, safe, and connected this hurricane season and beyond
By Life360, Inc. · Via GlobeNewswire · September 10, 2025
Rapport Therapeutics, Planet Labs, QuantumScape, EchoStar And Other Big Stocks Moving Higher On Mondaybenzinga.com
Via Benzinga · September 8, 2025
Alterity Therapeutics Raises A$20.0 million in Strategic Placement
MELBOURNE, Australia and SAN FRANCISCO, Sept. 08, 2025 (GLOBE NEWSWIRE) -- Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) (“Alterity” or “the Company”), a biotechnology company dedicated to developing disease modifying treatments for neurodegenerative diseases, today announced it has received binding commitments for a capital raising of A$20.0 million (the “Placement”) of fully paid ordinary shares (“New Shares”) to International and Australian professional investors.
By ALTERITY THERAPEUTICS LIMITED · Via GlobeNewswire · September 8, 2025
Alterity Therapeutics to Present at the Biotech Showcase
MELBOURNE, Australia and SAN FRANCISCO, Sept. 02, 2025 (GLOBE NEWSWIRE) -- Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) (“Alterity” or “the Company”), a biotechnology company dedicated to developing disease modifying treatments for neurodegenerative diseases, today announced that David Stamler, M.D., Chief Executive Officer of Alterity, will deliver a corporate update at the Biotech Showcase hosted by Peak Asset Management and Monsoon Communications. The presentation will take place on Wednesday, 3 September 2025 in Australia; Tuesday, 2 September 2025 in the United States.
By ALTERITY THERAPEUTICS LIMITED · Via GlobeNewswire · September 2, 2025
OTC Markets Group Welcomes Amaero Limited to OTCQX
NEW YORK, Aug. 26, 2025 (GLOBE NEWSWIRE) -- OTC Markets Group Inc. (OTCQX: OTCM), operator of regulated markets for trading 12,000 U.S. and international securities, today announced Amaero Limited (ASX: 3DA; OTCQX: AMROF), a company specializing in the research, development, manufacture, and sale of refractory metals and specialty alloy powders, has qualified to trade on the OTCQX® Best Market. Amaero LTD. upgraded to OTCQX from the OTCQB® Venture Market.
By OTC Markets · Via GlobeNewswire · August 26, 2025
Life360 Launches No Show Alerts to Ease Parents’ Back-To-School Scheduling Stress
New Feature Alerts if a Loved One Doesn’t Make It Somewhere They’re Supposed to Be, Supporting Families During the Most Chaotic Time of the Year
By Life360, Inc. · Via GlobeNewswire · August 20, 2025
Life360 Reports Record Q2 2025 Results
Monthly Active Users Reached Approximately 88.0 million; Up 25% Year-Over-Year Record Q2 Global Net Additions of 136 thousand Paying Circles, Reaching 2.5 million TotalTotal Quarterly Revenue Increased 36% Year-Over-Year to $115.4 million Annualized Monthly Revenue Increased 36% Year-Over-Year to $416.1 millionFull-Year Outlook for Revenue and Adjusted EBITDA Raised Based on Year-To-Date Performance
By Life360, Inc. · Via GlobeNewswire · August 11, 2025
Life360 Names COO Lauren Antonoff as Chief Executive Officer
Co-Founder Chris Hulls will serve as Executive Chairman of the Board
By Life360, Inc. · Via GlobeNewswire · August 11, 2025
OTC Markets Group Welcomes Alkane Resources Limited to OTCQX
NEW YORK, Aug. 06, 2025 (GLOBE NEWSWIRE) -- OTC Markets Group Inc. (OTCQX: OTCM), operator of regulated markets for trading 12,000 U.S. and international securities, today announced Alkane Resources Limited (ASX: ALK; OTCQX: ALKEF), a diversified Australia-based gold and antimony producer, has qualified to trade on the OTCQX® Best Market. Alkane Resources Limited upgraded to OTCQX from the Pink® market.
By OTC Markets · Via GlobeNewswire · August 6, 2025
Gabelli Funds to Host 31st Annual Aerospace & Defense Symposium at The Harvard Club, New York City Thursday, September 4, 2025
GREENWICH, Conn., Aug. 11, 2025 (GLOBE NEWSWIRE) -- Gabelli Funds, LLC, is hosting our annual Aerospace & Defense Symposium at The Harvard Club in New York City on September 4th. The conference will draw top executives from more than ten companies, with a focus on the themes of strong demand outlook, high barriers to entry, large aftermarket opportunity, growth in excess of GDP, defense spending, and M&A potential for the Aerospace and Defense industry. Attendees will also have the opportunity to meet with management in a one-on-one setting. Prospective attendees can learn more about the symposium on our website.
By Gabelli Funds · Via GlobeNewswire · August 11, 2025
OTC Markets Group Welcomes Talga Group Ltd. to OTCQX
NEW YORK, Aug. 01, 2025 (GLOBE NEWSWIRE) -- OTC Markets Group Inc. (OTCQX: OTCM), operator of regulated markets for trading 12,000 U.S. and international securities, today announced Talga Group Ltd. (ASX: TLG; OTCQX: TLGRF), a leader in the development of sustainable battery materials, has qualified to trade on the OTCQX® Best Market. Talga Group Ltd. upgraded to OTCQX from the Pink® market.
By OTC Markets · Via GlobeNewswire · August 1, 2025
Appendix 4C – Q4 FY25 Quarterly Cash Flow Report
Highlights
By ALTERITY THERAPEUTICS LIMITED · Via GlobeNewswire · July 30, 2025